CoChat
Cited by 175

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Low neoantigen expression and poor T-cell priming underlie early immune escape in colorectal cancer

Open access
Westcott, Peter M. K., Sacks, Nathan J., Schenkel, Jason M., Ely, Zackery A., Smith, Olivia, Hauck, Haley, Jaeger, Alex M., Zhang, Daniel, Backlund, Coralie M., Beytagh, Mary C., Patten, J. J., Elbashir, Ryan, Eng, George, Irvine, Darrell J., Yilmaz, Omer H., Jacks, Tyler · 2021 · Nature Cancer

Abstract

Immune evasion is a hallmark of cancer and therapies that restore immune surveillance have proven highly effective in cancers with high tumor mutation burden (TMB) (for example, those with microsatellite instability). Whether low TMB cancers, which are largely refractory to immunotherapy, harbor potentially immunogenic neoantigens remains unclear. Here, we show that tumors from all patients with microsatellite stable colorectal cancer express clonal predicted neoantigens despite low TMB. Unexpectedly, these neoantigens are broadly expressed at lower levels compared to those in colorectal cancer with microsatellite instability. Using a versatile platform for modulating neoantigen expression in colorectal cancer organoids and transplantation into the distal colon of mice, we show that low expression precludes productive cross-priming and drives immediate T-cell dysfunction. Notably, experimental or therapeutic rescue of priming rendered T cells capable of controlling tumors with low neoantigen expression. These findings underscore a critical role of neoantigen expression level in immune evasion and therapy response. Jacks and colleagues demonstrate the effects of neoantigen expression level on T-cell priming and immune surveillance during tumor development and progression and explore implications for immunotherapies, using in vivo models of colorectal cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s43018-021-00247-z

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 175

Metadata

Authors
Westcott, P. M. K., Sacks, N. J., Schenkel, J. M., Ely, Z. A., Smith, O., Hauck, H., Jaeger, A. M., Zhang, D., Backlund, C. M., Beytagh, M. C., Patten, J. J., Elbashir, R., Eng, G., Irvine, D. J., Yilmaz, O. H., & Jacks, T.
Venue
Nature Cancer
Published
2021-09-30
Volume
2
Issue
10
Pages
1071-1085
ISSN
2662-1347 (ISSN-L)
OpenAlex
W3202063872
Cited by
175
References
25
FWCI
7.26
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Low neoantigen expression and poor T-cell priming underlie early immune escape in colorectal cancer. https://app.cochat.ai/papers/10.1038/s43018-021-00247-z
The paper
Westcott, P. M. K., Sacks, N. J., Schenkel, J. M., Ely, Z. A., Smith, O., Hauck, H., Jaeger, A. M., Zhang, D., Backlund, C. M., Beytagh, M. C., Patten, J. J., Elbashir, R., Eng, G., Irvine, D. J., Yilmaz, O. H., & Jacks, T. (2021). Low neoantigen expression and poor T-cell priming underlie early immune escape in colorectal cancer. Nature Cancer. https://doi.org/10.1038/s43018-021-00247-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.